Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | USP2 | O75604 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25477463 | 0.86 | CYP1A2 (0.39) | ALDH1A1USP2GAAMAPTCYP1A2 | |
| SCHEMBL24718649 | 0.86 | TSHR (0.33) | CYP1A2CYP2D6ALOX15 | |
| SCHEMBL24589000 | 0.86 | TSHR (0.33) | CYP1A2CYP2D6ALOX15 | |
| SCHEMBL18624721 | 0.83 | USP2 (0.30) | ALDH1A1USP2CYP1A2CYP2D6 | |
| SCHEMBL15369596 | 0.81 | — | — | |
| SCHEMBL24269153 | 0.81 | CYP1A2 (0.33) | ALDH1A1USP2GAAMAPTCYP1A2 | |
| SCHEMBL18435072 | 0.77 | CYP1A2 (0.35) | ALDH1A1CYP1A2CYP2D6ALOX15TDP1 | |
| SCHEMBL19766337 | 0.77 | CYP1A2 (0.36) | ALDH1A1USP2GAAMAPTCYP1A2 | |
| SCHEMBL18624720 | 0.75 | TSHR (0.31) | — | |
| SCHEMBL15472720 | 0.74 | TSHR (0.35) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230192677-A1 | CYP11A1 INHIBITORS | ORION CORPORATION (FI) | 2023-06-22 | — | — | US | disclosed |
| US-20230192677-A1 | CYP11A1 INHIBITORS | ORION CORPORATION (FI) | 2023-06-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230192677-A1 | CYP11A1 INHIBITORS | CYP11B1, CYP11B2, CYP17A1 | ALDH1A1 176/4885USP2 4400/4885GAA 1595/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.